Home › Leukoencephalopathies › Massachusetts
Leukoencephalopathies clinical trials in Massachusetts
4 studies for Leukoencephalopathies are looking for participants at sites in Massachusetts.
Cities in Massachusetts
An Open-Label Exploratory Study of Fosigotifator in Participants With Vanishing White Matter Disease
- Massachusetts General Hospital /ID# 270960, Boston
RecruitingPhase 1/2
6 Months · All sexes · Updated Sep 24, 2026 · NCT05757141A Study of AAV9 Gene Therapy in Participants With Canavan Disease (CANaspire Clinical Trial)
- Massachusetts General Hospital (MGH); Center for Rare Neurological Diseases (CRND), Boston
RecruitingPhase 1/2
30 Months · All sexes · Updated Apr 17, 2026 · NCT04998396North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
- Massachusetts General Hospital, Boston
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Feb 4, 2026 · NCT01694940The Myelin Disorders Biorepository Project
- Massachusetts General Hospital (MGH), Boston
RecruitingObservational study
All ages · All sexes · Updated Oct 23, 2025 · NCT03047369From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.